Consolidated Income Statement

| MSEK |
Note |
2007 |
2006 |
| Net sales, including tobacco tax |
|
22,852 |
21,991 |
| Less tobacco tax |
|
–10, 301 |
–9,080 |
| Net sales |
2, 3 |
12,551 |
12,911 |
| |
|
|
|
| Cost of sales |
|
–6,578 |
–6,674 |
| Gross profit |
|
5,973 |
6,237 |
| |
|
|
|
| Other income |
5 |
7 |
1 |
| Selling expenses |
|
–2,260 |
–2,148 |
| Administrative expenses |
|
–720 |
–801 |
| Other expenses |
5 |
–4 |
–16 |
| Share of profit in equity accounted investees |
14 |
1 |
11 |
| Operating profit |
3, 5, 7, 8 |
2,997 |
3,285 |
| |
|
|
|
| Financial income |
|
165 |
239 |
| Financial expenses |
|
–501 |
–351 |
| Net finance cost |
9 |
–336 |
–112 |
| |
|
|
|
| Profit before income tax |
|
2,662 |
3,173 |
| |
|
|
|
| Income tax expense |
10 |
–606 |
–838 |
| Profit for the year |
|
2,056 |
2,335 |
| |
|
|
|
| Attributable to: |
|
|
|
| Equity holders of the Parent |
|
2,055 |
2,335 |
| Minority interest |
|
1 |
1 |
| Profit for the year |
|
2,056 |
2,335 |
| |
|
|
|
| Earnings per share |
21 |
|
|
| basic, SEK |
|
7.82 |
8.13 |
| diluted, SEK |
|
7.80 |
8.10 |
Consolidated Balance Sheet

| MSEK |
Note |
December 31, 2007 |
December 31, 2006 |
| Assets |
|
|
|
| Intangible assets |
11 |
4,419 |
3,469 |
| Property, plant and equipment |
12 |
2,297 |
2,138 |
| Biological assets |
13 |
91 |
83 |
| Investment in associates |
14 |
89 |
90 |
| Non-current receivables |
15 |
558 |
487 |
| Deferred tax assets |
10 |
365 |
477 |
| Total non-current assets |
|
7,818 |
6,744 |
| |
|
|
|
| Inventories |
16 |
2,520 |
2,473 |
| Trade receivables |
17 |
2,022 |
1,891 |
| Prepaid expenses and accrued income |
|
132 |
107 |
| Income tax receivables |
|
145 |
74 |
| Other receivables |
15 |
386 |
535 |
| Other investments |
18 |
5 |
56 |
| Cash and cash equivalents* |
18 |
3,439 |
3,042 |
| Assets held for sale |
19 |
– |
747 |
| Total current assets |
|
8,649 |
8,925 |
| TOTAL ASSETS |
|
16,467 |
15,670 |
| |
|
|
|
| Equity |
20 |
|
|
| Share capital |
|
390 |
390 |
| Reserves |
|
–486 |
–256 |
| Retained earnings |
|
816 |
1,903 |
| Equity attributable to equity holders of the Parent |
|
720 |
2,037 |
| Minority interest |
|
4 |
3 |
| TOTAL EQUITY |
|
724 |
2,041 |
| |
|
|
|
| Liabilities |
|
|
|
| Loans and borrowings |
22, 27 |
8,768 |
7,815 |
| Other liabilities |
25 |
12 |
4 |
| Provision for pensions and similar obligations |
23 |
555 |
652 |
| Other provisions |
24 |
597 |
566 |
| Deferred tax liabilities |
10 |
695 |
626 |
| Total non-current liabilities |
|
10,627 |
9,664 |
| |
|
|
|
| Loans and borrowings |
22, 27 |
1,271 |
409 |
| Accounts payable |
|
738 |
724 |
| Income tax liabilities |
10 |
258 |
119 |
| Other liabilities |
25 |
2,007 |
1,825 |
| Accrued expenses and deferred income |
26 |
782 |
826 |
| Provisions |
24 |
60 |
61 |
| Total current liabilities |
|
5,117 |
3,965 |
| TOTAL LIABILITIES |
|
15,743 |
13,629 |
| TOTAL EQUITY AND LIABILITIES |
|
16,467 |
15,670 |
| For information on the Group’s pledged assets and contingent liabilities, see Note 29 and Note 30. * Cash and cash equivalents include current investments with maturity of less than 90 days from acquisition. |
|
|